ALPHAHELIX MOLECULAR DIAGNOSTICS AB

All News AlphaHelix Molecular Diagnostics AB

Equities

LEVBIO

SE0000885501

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
0.32 ^SEK	+3.23%		+23.08%	-21.57%

Apr. 25	Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 22	AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter Ended September 30, 2023	23-10-26	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-23	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-27	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-21	CI
AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-17	CI
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Alphahelix Molecular Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-22	CI
Alphahelix Molecular Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-17	CI
Xanadu Technologies AB, Tataa Biocenter AB and Active Healthtech Nordic AB acquired a 13.17% stake in AlphaHelix Molecular Diagnostics AB from Labkompaniet AB.	20-05-05	CI
AlphaHelix Molecular Diagnostics AB Appoints Peter Herte as Chief Executive Officer, Effective May 23, 2017	17-05-10	CI
AlphaHelix Molecular Diagnostics AB Auditor Raises 'Going Concern' Doubt	13-06-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
LEVBIO Stock
News AlphaHelix Molecular Diagnostics AB

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW